Zealand Pharma: Royce & Associates cuts stake to below 5%
(CercleFinance.com) - Small-cap fund specialist Royce & Associates has cut its stake in the Danish biotechnology company Zealand Pharma to below 5%, according to a regulatory filing on Monday.
The New York-based pioneer in small-cap investing, which claims to have funds under management of 17.6 billion dollars, now holds 1,534,556 shares million Zealand shares, or 4.99% of the company's outstanding shares, according to details in the filing.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The New York-based pioneer in small-cap investing, which claims to have funds under management of 17.6 billion dollars, now holds 1,534,556 shares million Zealand shares, or 4.99% of the company's outstanding shares, according to details in the filing.
Copyright (c) 2018 CercleFinance.com. All rights reserved.